MDT

86.05

+0.2%↑

114.6

+0.02%↑

VEEV

173.01

-0.02%↓

HQY

84.23

+1.14%↑

PHR.US

8.4

-1.18%↓

MDT

86.05

+0.2%↑

114.6

+0.02%↑

VEEV

173.01

-0.02%↓

HQY

84.23

+1.14%↑

PHR.US

8.4

-1.18%↓

MDT

86.05

+0.2%↑

114.6

+0.02%↑

VEEV

173.01

-0.02%↓

HQY

84.23

+1.14%↑

PHR.US

8.4

-1.18%↓

MDT

86.05

+0.2%↑

114.6

+0.02%↑

VEEV

173.01

-0.02%↓

HQY

84.23

+1.14%↑

PHR.US

8.4

-1.18%↓

MDT

86.05

+0.2%↑

114.6

+0.02%↑

VEEV

173.01

-0.02%↓

HQY

84.23

+1.14%↑

PHR.US

8.4

-1.18%↓

Home・Aktien・Lisata Therapeutics

L
Lisata Therapeutics

Open

5.01 0.2

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

Max

5.01

Schlüsselkennzahlen
By Trading Economics
Einkommen	1.3M -3M
Verkäufe	100K 100K
Gewinnspanne	-2,954
Angestellte	21

Dividenden
By Dow Jones
Nächstes Ergebnis	7. Mai 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	531K 40M
Vorheriger Eröffnungskurs	4.81
Vorheriger Schlusskurs	5.01

Lisata Therapeutics Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

1. Apr. 2026, 22:56 UTC

Wichtige Nachrichtenereignisse

Australian PM Set To Announce Interest-Free Loans For Businesses, Farmers

1. Apr. 2026, 20:50 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Extends Deadline on Tender Offer to Acquire Arcellx

1. Apr. 2026, 23:55 UTC

Market Talk

Gold Rises on Hopes for Early End to U.S.-Iran Conflict -- Market Talk

1. Apr. 2026, 23:43 UTC

Market Talk

Nikkei May Rise on Continued Hopes for U.S. Ending Iran War -- Market Talk

1. Apr. 2026, 23:23 UTC

Wichtige Nachrichtenereignisse

South Korea Consumer Inflation Accelerates on Mideast Energy Shock -- Update

1. Apr. 2026, 23:07 UTC

Ergebnisse

Shake Shack Leans on Loyalty Program and Tech to Drive Growth -- Barrons.com

1. Apr. 2026, 23:02 UTC

Wichtige Nachrichtenereignisse

South Korea Consumer Inflation Accelerates on Mideast Energy Shock

1. Apr. 2026, 23:00 UTC

Wichtige Nachrichtenereignisse

S Korea Mar CPI +0.3% on Month; +0.6% Forecast

1. Apr. 2026, 23:00 UTC

Wichtige Nachrichtenereignisse

S Korea Mar Core CPI +2.2% on Year, +0.1% on Month

1. Apr. 2026, 23:00 UTC

Wichtige Nachrichtenereignisse

S Korea Mar CPI +2.2% on Year; +2.4% Forecast

1. Apr. 2026, 22:39 UTC

Ergebnisse

Nike Can't Fix Its China Problem and That's Tanking Its Stock -- Update

1. Apr. 2026, 22:08 UTC

Market Talk

KKR BDC Joins Others in Capping Withdrawals at 5% -- Market Talk

1. Apr. 2026, 22:00 UTC

Wichtige Nachrichtenereignisse

Mideast War Rekindles Asia Inflation Risk, Says DBS Chief Economist -- Interview

1. Apr. 2026, 22:00 UTC

Wichtige Nachrichtenereignisse

DBS Chief Economist: Rate Hikes Seem Likely in Japan, Singapore, Australia

1. Apr. 2026, 22:00 UTC

Wichtige Nachrichtenereignisse

DBS Chief Economist: BOK Could Also Take Proactive Approach Like RBA

1. Apr. 2026, 22:00 UTC

Wichtige Nachrichtenereignisse

DBS Chief Economist: India Vulnerable to War Imapct on Both Trade, Energy

1. Apr. 2026, 22:00 UTC

Wichtige Nachrichtenereignisse

DBS Chief Economist: China, Malaysia Looks Relatively Well-Insulated From War Fallout

1. Apr. 2026, 22:00 UTC

Wichtige Nachrichtenereignisse

DBS Chief Economist: Mideast Crisis Won't Hurt Asia Growth Much, Inflation a Bigger Issue

1. Apr. 2026, 22:00 UTC

Wichtige Nachrichtenereignisse

Inflationary Impact of Mideast Conflict Seems Inevitable, DBS Group Chief Economist Says

1. Apr. 2026, 21:56 UTC

Akquisitionen, Fusionen, Übernahmen

BHP Completes $4.3 Billion Silver Streaming Agreement With Wheaton Precious Metals

1. Apr. 2026, 21:31 UTC

Wichtige Nachrichtenereignisse

End to Iran War Could Trigger Relief Rally in These 2 Assets -- Barrons.com

1. Apr. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

1. Apr. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

1. Apr. 2026, 20:38 UTC

Ergebnisse

Why Nike Stock Is in 'Penalty Box' After Earnings Beat -- Barrons.com

1. Apr. 2026, 20:31 UTC

Akquisitionen, Fusionen, Übernahmen

Arsenal Capital Partners Completes Sale of ATP Adhesive Systems to Henkel

1. Apr. 2026, 20:16 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead: Tender Offer Extended to Expire at 5 p.m. EDT on April 24 >GILD

1. Apr. 2026, 20:16 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead: Offer Remains at a Purchase Price of $115.00 per Shr >GILD

1. Apr. 2026, 20:13 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Extends Tender Offer To Acquire Arcellx >GILD

1. Apr. 2026, 20:07 UTC

Market Talk

Mexican Manufacturing Indexes Pick Up in March -- Market Talk

1. Apr. 2026, 20:07 UTC

Akquisitionen, Fusionen, Übernahmen

Why 2026 Is Biotech's Comeback Year -- Barrons.com

Peer-Vergleich

Kursveränderung

Lisata Therapeutics Prognose

Rating-Konsens

By TipRanks

Neutral

1 ratings

Buy

Halten

Sell

Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lisata Therapeutics – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Gewinn vor Steuern

Verkäufe

Betriebsergebnis

Über Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.